Price Alert

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

53.26

-2.74 (-4.89%)

At close: Oct 03, 2025, 3:59 PM

53.26

0.00%

After-hours: Oct 03, 2025, 06:06 PM EDT

-4.89% (1D)

Bid	50.51
Market Cap	377.35M
Revenue (ttm)	n/a
Net Income (ttm)	-8.89M
EPS (ttm)	-0.99
PE Ratio (ttm)	-53.8
Forward PE	-10.98
Analyst	Buy
Dividends	n/a

Ask	58.68
Volume	99,668
Avg. Volume (20D)	65,963
Open	56.00
Previous Close	56.00
Day's Range	53.16 - 56.40
52-Week Range	0.94 - 79.02
Beta	-0.35
Ex-Dividend Date	n/a

About DRUG

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DRUG

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+3.36%

Shares of psychedelic companies are trading higher... Unlock content with Pro Subscription

10 months ago

-1.24%

Bright Minds Biosciences shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $75.

News

2 weeks ago · zacks.com

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade

The consensus price target hints at an 81.3% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward tren...

1 month ago · zacks.com

Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?

The consensus price target hints at an 114.1% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward tre...